Amgen, Inc. (AMGN)
353.82
+16.09
(+4.76%)
USD |
NASDAQ |
Jun 11, 16:00
354.60
+0.78
(+0.22%)
After-Hours: 18:59
Amgen Accounts Payable (Quarterly) : 2.935B for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 2.935B |
| December 31, 2025 | 2.367B |
| September 30, 2025 | 2.838B |
| June 30, 2025 | 3.01B |
| March 31, 2025 | 2.406B |
| December 31, 2024 | 1.908B |
| September 30, 2024 | 2.147B |
| June 30, 2024 | 2.267B |
| March 31, 2024 | 1.628B |
| December 31, 2023 | 1.59B |
| September 30, 2023 | 1.358B |
| June 30, 2023 | 1.212B |
| March 31, 2023 | 1.32B |
| December 31, 2022 | 1.572B |
| September 30, 2022 | 1.204B |
| June 30, 2022 | 1.256B |
| March 31, 2022 | 1.403B |
| December 31, 2021 | 1.366B |
| September 30, 2021 | 1.171B |
| June 30, 2021 | 1.277B |
| March 31, 2021 | 1.396B |
| December 31, 2020 | 1.421B |
| September 30, 2020 | 1.161B |
| June 30, 2020 | 1.15B |
| March 31, 2020 | 1.338B |
| Date | Value |
|---|---|
| December 31, 2019 | 1.371B |
| September 30, 2019 | 1.005B |
| June 30, 2019 | 1.001B |
| March 31, 2019 | 1.091B |
| December 31, 2018 | 1.207B |
| September 30, 2018 | 1.042B |
| June 30, 2018 | 1.026B |
| March 31, 2018 | 1.089B |
| December 31, 2017 | 1.352B |
| September 30, 2017 | 879.00M |
| June 30, 2017 | 883.00M |
| March 31, 2017 | 902.00M |
| December 31, 2016 | 917.00M |
| September 30, 2016 | 825.00M |
| June 30, 2016 | 870.00M |
| March 31, 2016 | 818.00M |
| December 31, 2015 | 965.00M |
| September 30, 2015 | 1.067B |
| June 30, 2015 | 934.00M |
| March 31, 2015 | 888.00M |
| December 31, 2014 | 1.212B |
| September 30, 2014 | 955.00M |
| June 30, 2014 | 982.00M |
| March 31, 2014 | 949.00M |
| December 31, 2013 | 787.00M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Biogen, Inc. | 358.50M |
| Gilead Sciences, Inc. | 645.00M |
| Regeneron Pharmaceuticals, Inc. | 1.027B |
| AbbVie, Inc. | 33.61B |
| Viridian Therapeutics, Inc. | 13.31M |